tv White House COVID-19 Task Force Holds Briefing CSPAN March 25, 2021 6:46am-7:20am EDT
>> thank you dr. fauci dr. walinski let's take some questions. >> great first we'll go to cnbc. >> thank you so much. i wonder first if you could just address what happened yesterday with the vaccine and data safety monitoring board i know you talked about it a number of times yesterday but if you can provide anymore clarity it seem leak from the reporting in "the washington post" and "new york times" that, efficacy was closer to 69 to 74%s that not different from astrazeneca released if you could just provide anymore clarity on that it would be extremely helpful and for dr. washington walinski wonderiw looking at b1256 and we spoke to new york city health commissioner saying it is contradicting to that high case load they're seeing in the city there.
how are you looking at that and whether you might characterize it as a variant of concern rather than interest and is federal government looking at surging vaccines to places that are seeing more spread right now perhaps because of variants, thanks. >> thank you meg for that question. as i had explained multiple teams yesterday but briefly summarize it, again now, what happened was that the az company was dealing back and forth with the data in safety monitoring board regarding the efficacy point of their study. they then came out with a press release and briefed us at the nih and others regarding the efficacy of the vaccine. when they came out with their press release very soon thereafter, they received from the data and safety monitoring beard with a copy to me and others that the data and safety monitoring board was quite concerned that the data that was
reflect in the press release was not most recent updated data that was more accurately reflective of what the vaccine efficacy point was. on the basis of that, seasons we ourselves i.e. the federal government in the form of the n.i.h. had put out a press release that reflected almost exactly what the az had done, we then put out a very brief release which said that we urged strongly that az get back to the data and safety monitoring board to make sure that the data that is made public is accurately reflecting of what the actual data was so that's the entire story. right now, az is getting back with the data and safety monitoring board and will likely come out with a modified statement. >> you set up by526 discussion
yes we're following this carefully across the northeast, and in new york as well as in new jersey. we're following the frequency of it and early data does increase transmissibility and to my understands not as transmissible as b127 there are interagency discussions about whether b1256 should be considered not just a variant of interest but wrather a variant of concern. >> one thing to your first question, meg. i think that our take away is the importance of transparency and trust, and what we do in these briefings is dr. fauci very kindly and clearly helps interpret scientific information for the public. but let's not mistake that for the process that people who are conducted clinical trials need to go through before they're
approved and deemed ready for the public. that will go through the food drug administration once in the u.a. applied that always been the case. we never look at numbers in a press release to make that determination that's always a much more in-depth submission. dr. fauci has always help interpret the results when that happens. so i would urge us not to focus on the process of the last couple of days. but instead to focus on what really matters which is what happens when these applications for these kaingts are submitted to the fda. next question. >> go jeff mason -- all right jeff we'll come back
to you. we'll go to -- ricardo at the ap. this is jeff i'm back now sorry if you can't hear me. >> we can hear you, jeff. apologies for that. j my question was first to follow-up for dr. fauci if you're concerned about hesitancy regard to astrazeneca vaccine once that is available in the u.s. and secondly for all of you if you can broadly say what you expect pace of vaccinations to be in april as it is 16 or 20 million right now. >> yeah, jeff thank you for that question we're always concerned when there is an apparent miscommunication if you want to use that word that that would add to an already existing level of vaccine hesitancy and that's
the reason why as andy said we want to make sure we're always completely transparent in everything that goes on with regard to a messaging and vaccine. at the end of the day you know when you look at the data this is going to turn out to be a good vaccine as andy said the final determination of the analysis of the data will be done by the fda. when that is done, that is going to be very transparent as they meet with their pack, their advisory committee. so at the end of the day everything is going to be open and transparent and hopefully that will dispel any hesitancy that was associated with this little bump in the road that we happen to have most recently with az. >> second question. which is on what to expect i think you said in april i'll tell you that last week, president biden said that he would, we would over the course
of this week make a commitment as to what our goal is for the upcoming period of time. so we're going to let the president do that and i think that will give you the information you need. next question please. >> all right. let's go back to ricardo at ap. >> okay can you hear me mow? can you hear me? >> yes ricardo. >> okay, thank you for taking my question and as i listen to you, it is hard to miss the sense of excitement in your voices as you rattle off the statistics and the change implied by those statistics. and i noticed this even with dr. walinski who is normally guarded. so would you state that we are
finally at the point where we have reached the long awaited turning the corner on the pandemic? and that's the doctors walinski and fauci. >> thank you for that question ricardo. yes i'm normally guarded i remain guarded indeed i'm enthusiastic about the pace of vaccination that is happening about the early data that we're seeing -- the changes and infection rates. the changes in emergency department rates, what worries me is that while we have about 24% of the population who has received one dose and about 13% of the population that is fully vaccinated. what concerns me is the footage of what is happening in spreng breakers, in people who are not continuing to have strategies while we get fully scaled up we're at 13% we need to be much
higher of that to have adequate protection around this country so early data really encouraging and that's why i'm so -- i emphasized how we need to hang in there for just a little while longer. because we can see at times in the next couple of months where we'll have a lot more people vaccinated and we'll really be able to blend infection rates we're hanging out at 55,000 cases day and we're watching what is happening as people who are vacationing right now and that concerns me a lot. >> yeah just underscore what dr. walinski asked are we turning the corner my response is really more like we are at the corner whether or not we're going to be turning that corner still remains to be seen depending upon what dr. walinski said not to repeat it. we do have a lot of challenges in front of us with regard to high level of daily infections
yesterday being 54,974. when you're at that level, i don't think you can declare victory and say you've turned the corner. you've got to continue to do what we're doing. more vaccinations and continue to do public health measures until we actually do turn the corner. >> dr. fauci reiterate one thing that was very clear in your presentation in your slides which i hope is coming clear to the american public. which is that these vaccines are being proven to work. and i think that's an extraordinarily positive statement and a path out in the midst of continued very challenging information. so i don't know if you want to reiterate that perspective. >> yeah. i think that graph i showed andy on the second slide really speaks for itself. if you look at the level of infection and individuals who were doubly vaccinated with the vaccine, it was 0.05% that's extremely low that's where we
want to be. when as a country, we're at that level, we will have turned the corner. >> great. next question please. >> next we'll go to raquel at tv global brazil. >> thank you so much. ready for the opportunity can you hear these? >> yes. >> i have one question about vaccination and another one about dr. fauci because world health organization warned this week that between vaccines in the arms of people in countries in the number of vaccine through kovac is drawing becoming more grotesque every day and false sense of security in these countries. do you believe global inequality of vaccination hoarding if you want to call that could make funding last longer and dr. fauci, are you meeting brazilian health officials this week. do you believe the administration should let
astrazeneca supply -- also to countries that most need it and do you believe that ward should help brazil and other places -- >> andy you want to answer the first question i'll answer the second? >> so i don't know exactly know how to parse pieces first question was -- was with regard to the supply of in rich countries versus in more developing countries is that the question right? >> look, we i think let me just start with this. the president has stated number one priority is to make sure we prioritize the vaccination in this country. we've suffered over 540,000 deaths. more than anywhere else in the world and he came at office came into office with a seriousness of purpose to make sure that we
make this country safe again. we have procured vaccine supplies vaccination sites, increased number of vaccinators. at the same time, dr. fauciling go into, we've also made it a priority to say that we must return to global leadership and indeed as your question correctly points out, until we deal with this pandemic across the globe, we will not be successful in dealing with it. so our work with kovac to make leading investment in first investment get that moving quickly -- dr. fauci on the first day attending world health organizations meeting, our recent announce that time we're moving the vaccine in this hemisphere to mexico and canada are work with the quad to develop longer term manufacturing capacity around the world. these are efforts that are active and ongoing. and before i turn it over to dr. fauci i would just say we are, in fact, concerned with the situation in brazil.
we are having conversations in with the folks in brazil on a regular basis and daily basis about what is going on there and won't give you more details other than to say that we're deeply engaged. let me turn it over to dr. fauci. >> thank you andy yes we will be meeting with brazilian authorities to reiterate what andy said we are quite concerned about difficult situation in brazil. and we will be discussing ways that we might be able to be helpful to brazil i can't go over the details -- i like to wait to see what their presentation and how in the future we might be tiebl help them but also as andy said, we really are now taking a very active role in covax. we have a $4 billion pledge we'll be doing we're back in global leadership i think is really important. and as said after we do take care of the really difficult situation we've had in our own country with over 535,000 deaths, we will, obviously, in
the future have surplus vaccine in certainly a consideration for making that vaccine available to countries that need it. >> next question please. >> last question we'll go to chris at the detroit free press. >> thanks for taking me question in michigan we're seeing big increase in covid-19 outbreaks and k-12 schools since many reopened face-to-face learning earlier this month. and while teachers have been able to get vaccinated kids are not and with b177 variant circulating heavily in state now it is leading to shut down again in schools what is the benefit of reopening schools only to see so many have to close again a couple of weeks later? and how should states manage such outbreak with variant cases circulating? and is this three foot spacing rule in school districts and in states where we have heavy variant spread a good idea?
thank you. >> dr. walinski. >> yeah. i think that, you know, our guidance that was put out early in february and then updated last week had a layer of mitigation approach and it has approached by different ranges of transmissions. so areas with high transmissions we're limiting what we're recommending for in person attendance in middle school and high schools because of potential increase transmission for older students. so we -- we believe and science suggest that would be possible if possible and it is safe when all of the layer of strategies that we have suggested and recommended are in place. so hundred percent mask should be safe with all of your schools as long as you're talking about the younger children. and so, yes, we need to watch the by17 spread we certainly don't want schools to open and
then reclose. the whole point is to keep schools open. in the context of all of the layer mitigation that we put forward through the redgeses. recommendations. >> great. well thank you all for attending today and for your questions. we will be back with another briefing on friday. go c-span.org/coronavirus for federal response to coronavirus pandemic if you missed our live coverage easy to find biden administration response, using interactive gallery of maps to follow cases in the u.s. and worldwide go to c-span.org/coronavirus. coming up today on c-span, the senate home langtd security committee holds confirmation hearing at 10:15 a.m. eastern, for fema administrator nominee dee i can. then at 1:15 president biden holds first official news conference since taking offings and senate back to consider an extension to the paycheck
protection loan program through the end of may. senators are also expected to vote on president biden's nominee for deputy treasury secretary. at noon on c-span 3, the ceos of facebook, twitter and google testify about the spread of online misinformation at a house energy and commerce sub committee hearing. and there's more streaming live on our website, including an infrastructure hearing with transportation secretary pete buttigieg and dennis mcdonough testifies on d.a. operations that gets underway at 2 p.m. eastern. sexual assault victims and victim advocated testify on preventing such cases in the military. the senate arm services sub committee and personnel is considering various proposals including making changes to the military justice system.